Huichuang Medical
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | Seed | |
CNY20.0m | Series A | ||
* | CNY100m | Series A | |
* | CNY100m | Series B | |
* | CNY100m | Series B | |
Total Funding | CAD60.0m |
Recent News about Huichuang Medical
EditHCmedx specializes in leveraging functional near infrared spectroscopy (fNIRS) technology to enhance adaptive decision-making and emotion regulation across various applications. The company focuses on providing advanced monitoring and evaluation tools that utilize fNIRS to assess brain activity and cortical activation. Their solutions are particularly impactful in environments such as air traffic control and rehabilitation, where precise and adaptive decision-making is critical. HCmedx serves a diverse range of clients, including healthcare providers, rehabilitation centers, and research institutions. Operating in the medical technology and neuroscience markets, the company employs a business model centered around the development and sale of specialized fNIRS-based products and services. Revenue is generated through product sales, service contracts, and research collaborations.
Keywords: fNIRS, adaptive decision-making, emotion regulation, brain activity, cortical activation, air traffic control, rehabilitation, neuroscience, medical technology, monitoring tools.